Why These 24 Stocks Are Skyrocketing

Page 13 of 23

11. uniQure N.V. (NASDAQ:QURE)

Q4 Returns as of December 31, 2024: 258%

Uniqure NV (QURE), an emerging leader in gene therapy, registered a 258% jump in its stock price in Q4 2024, closing the quarter at $17.66, up from $4.93 on September 30, 2024.

QURE boasts a solid growth opportunity, having increased its revenue by $0.8 million in Q3 2024 from the same period in 2023. The stock’s growth trajectory can also be explained by its liquidity situation, after having retired nearly $50 million of its outstanding debt, reducing annual interest expense by nearly $5 million.

Wall Street is also positive on the stock, posting an upside of 39% to its median price target of $25. At the same time, on December 19, 2024, analyst firm Mizuho raised its price target from $7 to $20, and on December 12, 2024, Goldman Sachs increased its price target for QURE to $20 from $9.

Page 13 of 23